TREMFYA® MAY BE THE TREATMENT YOU'VE BEEN WAITING FOR
If you've tried it all for your moderate to severe plaque psoriasis—like steroids, topical creams, or phototherapy—and still didn't get the results you wanted, it may be time to try TREMFYA®, the first biologic to selectively block interleukin-23 (IL-23).
Individual results may vary. You and your doctor can decide if TREMFYA® is right for you.
RESULTS WITH TREMFYA®
TREMFYA® gives you results you can see and feel.
In clinical studies at 16 weeks, at least 7 out of 10 patients saw 90% clearer skin and more than 80% were rated cleared or almost cleared.
In a clinical study, nearly 9 out of 10 people who saw 90% clearer skin at 28 weeks continued to see 90% clearer skin at 48 weeks while on TREMFYA®.
WORKS BETTER THAN HUMIRA®:
In clinical studies, TREMFYA® worked better than Humira® (adalimumab) at providing clearer skin.
Results are reflective of patients studied in the United States and Canada.
Individual results may vary.
TREMFYA® is not for everyone. Only you and your dermatologist can decide if TREMFYA® is right for you.
TREMFYA® is a 100 mg injection given under the skin as directed by your doctor at weeks 0 and 4, and every 8 weeks thereafter.
Hold and drag
Photos are of a real patient who achieved at least 90% clearer skin at week 48 in the VOYAGE 2 clinical study after receiving TREMFYA® 100 mg at weeks 0, 4, and then every 8 weeks through week 48.
Individual results may vary.
WHAT IS A BIOLOGIC?
Biologics are medicines that work to target an overactive immune system, a possible cause of plaque psoriasis. Most biologics, including TREMFYA®, may be given as an injection under your skin at your doctor’s office. Your first self-injection may be performed at your dermatologist’s office so he or she can show you the right way to give yourself injections under the skin. After this training, and with your healthcare provider’s approval, you may be able to inject at home.
HOW TREMFYA® WORKS
TREMFYA® is the first-in-class biologic that selectively blocks interleukin-23 (IL-23), one of the key proteins thought to be responsible for the symptoms of plaque psoriasis. The exact cause of plaque psoriasis is unknown, but research suggests that an overactive immune system causes skin cells to pile up on the surface of the skin, forming plaques.
DOSING WITH TREMFYA®
TREMFYA® is given as an injection under your skin that you only need to take once every 8 weeks, after 2 starter doses at weeks 0 and 4. That’s about 2 whole months that you don’t have to think about your treatment schedule.
Your first self-injection may be performed at your dermatologist’s office so he or she can show you the right way to give yourself injections under the skin. After this training, and with your healthcare provider’s approval, you may be able to inject at home. See how TREMFYA® dosing stacks up.
FIRST 52 WEEKS OF THERAPY:
1 DOSE EVERY 8 WEEKS
(After 2 starter doses at weeks 0 and 4)
1 DOSE EVERY OTHER WEEK
(Starting one week after the first dose of 80 mg)
TREMFYA® is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light or UV light).
Humira® is a prescription medicine used to treat adults with moderate to severe chronic plaque psoriasis who are ready for systemic therapy or phototherapy, and are under the care of a doctor who will decide if other systemic therapies are less appropriate.
The injection demonstration videos and guides are not meant to replace the Instructions for Use that come with your TREMFYA® medication. Please read those instructions before using your TREMFYA® prefilled syringe and each time you get a refill.